A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
POETYK SjS-1
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)
3 other identifiers
interventional
774
32 countries
197
Brief Summary
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Sep 2023
Longer than P75 for phase_3
197 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2023
CompletedFirst Posted
Study publicly available on registry
July 14, 2023
CompletedStudy Start
First participant enrolled
September 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 16, 2028
April 1, 2026
March 1, 2026
3.2 years
July 7, 2023
March 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI) Score at Week 52
Baseline, Week 52
Secondary Outcomes (19)
Change from baseline in European League Against Rheumatism Sjögren's Syndrome Patient Reported Index (ESSPRI) Score at Week 52
Baseline, Week 52
Number of participants with decrease in ESSPRI ≥ 1 or 15% from baseline at Week 52
Baseline, Week 52
Number of participants with decrease in ESSDAI ≥ 3 points from baseline at Week 52
Baseline, Week 52
Number of participants with ESSDAI < 5 at Week 52
Baseline, Week 52
Change from baseline in ESSDAI at Week 24
Baseline, Week 24
- +14 more secondary outcomes
Study Arms (3)
Deucravacitinib, Dose 1
EXPERIMENTALDeucravacitinib, Dose 2
EXPERIMENTALPlacebo, followed by Deucravacitinib Dose 1 or Dose 2
PLACEBO COMPARATORInterventions
Specified dose on specified days
Eligibility Criteria
You may qualify if:
- Satisfy the 2016 American College of Rheumatology/European League Against Rheumatism criteria for the classification of SjS at screening (score ≥ 4), and who have disease duration (from time of initial clinical SjS diagnosis) of at least 16 weeks prior to screening.
- Have moderate to severe SjS ESSDAI ≥ 5.
- Short duration of disease (≤ 10 years) before screening.
- A stimulated whole salivary flow (SWSF) ≥ 0.05 mililiters/minute (mL/minute).
- Positive anti-Sjögren's syndrome-associated antigen A (anti-Ro/SSA) at screening.
You may not qualify if:
- Autoimmune disease other than SjS (for example, rheumatoid arthritis, systemic lupus erthrematosus \[SLE\], systemic sclerosis).
- Active fibromyalgia with pain symptoms or signs that would interfere with joint assessment or requiring adjustment in medication within the 3 months before screening to control symptoms; participants with fibromyalgia that is well controlled on stable treatment may otherwise be considered.
- Medical condition associated with sicca syndrome.
- Previous exposure to tyrosine kinase 2 (TYK2) inhibitors such as deucravacitinib or related compounds.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (199)
Local Institution - 0228
Fullerton, California, 92835, United States
Local Institution - 0222
La Palma, California, 90623, United States
Local Institution - 0218
San Francisco, California, 94143, United States
Local Institution - 0203
Santa Monica, California, 90404, United States
Local Institution - 0067
Denver, Colorado, 80230, United States
Local Institution - 0049
Clearwater, Florida, 33765, United States
Local Institution - 0226
Cooper City, Florida, 33024, United States
Local Institution - 0223
Sarasota, Florida, 34239, United States
Local Institution - 0140
Augusta, Georgia, 30912, United States
Local Institution - 0229
Lawrenceville, Georgia, 30046, United States
Local Institution - 0174
Skokie, Illinois, 60076, United States
Local Institution - 0016
Kansas City, Kansas, 66160, United States
Local Institution - 0017
Baton Rouge, Louisiana, 70836, United States
Local Institution - 0125
Monroe, Louisiana, 71203, United States
Local Institution - 0187
Baltimore, Maryland, 21224-2746, United States
Local Institution - 0173
Boston, Massachusetts, 02111, United States
Local Institution - 0131
Eagan, Minnesota, 55123, United States
Local Institution - 0138
Summit, New Jersey, 07901, United States
Local Institution - 0009
Albuquerque, New Mexico, 87106, United States
Local Institution - 0184
Mineola, New York, 11501, United States
Local Institution - 0224
Salisbury, North Carolina, 28144, United States
Local Institution - 0130
Duncansville, Pennsylvania, 16635, United States
Local Institution - 0022
Jackson, Tennessee, 38305, United States
Local Institution - 0144
Allen, Texas, 75013, United States
Local Institution - 0227
Katy, Texas, 77494, United States
Local Institution - 0175
Plano, Texas, 75024, United States
Local Institution - 0133
Seattle, Washington, 98195, United States
Local Institution - 0189
Spokane, Washington, 99204, United States
Local Institution - 0050
San Isidro, Alabama, 1643, Argentina
Local Institution - 0100
CABA, Buenos Aires, 1114, Argentina
Local Institution - 0003
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1123AAO, Argentina
Local Institution - 0019
Quilmes, Buenos Aires, 1878, Argentina
Local Institution - 0026
San Miguel de Tucumán, Tucumán Province, 4000, Argentina
Local Institution - 0137
CABA, 1405, Argentina
Local Institution - 0109
City of Buenos Aires, 1425, Argentina
Local Institution - 0061
Córdoba, X5004AUL, Argentina
Local Institution - 0120
Woodville South, South Australia, 5011, Australia
Local Institution - 0117
Graz, A-8036, Austria
Local Institution - 0087
Vienna, A-1180, Austria
Local Institution - 0172
Ghent, 9000, Belgium
Local Institution - 0170
Vitória, Espírito Santo, 29041-295, Brazil
Local Institution - 0106
Belo Horizonte, Minas Gerais, 30130-100, Brazil
Local Institution - 0091
Juiz de Fora, Minas Gerais, 36010-570, Brazil
Local Institution - 0055
Porto Alegre, Rio Grande do Sul, 90560-030, Brazil
Local Institution - 0018
São Paulo, São Paulo, 04266-010, Brazil
Local Institution - 0111
Uberlândia, 38405-320, Brazil
Local Institution - 0008
Plovdiv, 4001, Bulgaria
Local Institution - 0221
Sofia, 1618, Bulgaria
Local Institution - 0134
Vancouver, British Columbia, V5Z 1L7, Canada
Local Institution - 0063
Toronto, Ontario, M5T 2S8, Canada
Local Institution - 0004
Sherbrooke, Quebec, J1L 0H8, Canada
Local Institution - 0056
Trois-Rivières, Quebec, G8Z1Y2, Canada
Local Institution - 0136
Santiago, Providencia, 7501126, Chile
Local Institution - 0032
Viña del Mar, Región de Valparaíso, 2531172, Chile
Local Institution - 0097
Santiago, Santiago Metropolitan, 7500710, Chile
Local Institution - 0015
Santiago de Chlie, Santiago Metropolitan, 8207257, Chile
Local Institution - 0216
Santiago, 8350488, Chile
Local Institution - 0200
Valdivia, 5110683, Chile
Local Institution - 0153
Beijing, Beijing Municipality, 100034, China
Local Institution - 0156
Beijing, Beijing Municipality, 100044, China
Local Institution - 0160
Beijing, Beijing Municipality, 100191, China
Local Institution - 0155
Xiamen, Fujian, 361003, China
Local Institution - 0095
Guangzhou, Guangdong, 510080, China
Local Institution - 0212
Shenzhen, Guangdong, 518020, China
Local Institution - 0214
Zhengzhou, Henan, 450052, China
Local Institution - 0149
Wuhan, Hubei, 430030, China
Local Institution - 0094
Changsha, Hunan, 410011, China
Local Institution - 0158
Changsha, Hunan, 410024, China
Local Institution - 0150
Hohhot, Inner Mongolia, 10000, China
Local Institution - 0215
Nanjing, Jiangsu, 210008, China
Local Institution - 0159
Nanjing, Jiangsu, 210029, China
Local Institution - 0154
Suzhou, Jiangsu, 215006, China
Local Institution - 0177
Nanchang, Jiangxi, 330006, China
Local Institution - 0213
Nanchang, Jiangxi, 330006, China
Local Institution - 0162
Pingxiang, Jiangxi, 337099, China
Local Institution - 0101
Xi'an, Shaanxi, 710061, China
Local Institution - 0182
Taiyuan, Shan1xi, 030032, China
Local Institution - 0102
Shanghai, Shanghai Municipality, 200000, China
Local Institution - 0151
Shanghai, Shanghai Municipality, 200065, China
Local Institution - 0157
Shanghai Shi, Shanghai Sheng, 200011, China
Local Institution - 0178
Chengdu, Sichuan, 610041, China
Local Institution - 0179
Ürümqi, Xinjiang Sheng, 830001, China
Local Institution - 0181
Hangzhou, Zhejiang, 310003, China
Local Institution - 0152
Hangzhou, Zhejiang, 314408, China
Local Institution - 0161
Ningbo, Zhejiang, 315010, China
Local Institution - 0093
Wenzhou, Zhejiang, 325000, China
Local Institution - 0168
Barranquilla, Atlántico, 080003, Colombia
Local Institution - 0043
Chía, Cundinamarca, 250001, Colombia
Local Institution - 0037
Bogota D.C, 110221, Colombia
Local Institution - 0199
Helsinki, 00290, Finland
Local Institution - 0135
Kuopio, 70100, Finland
Local Institution - 0119
Turku, 20520, Finland
Local Institution - 0005
Amiens, 80054, France
Local Institution - 0073
Bordeaux, 33075, France
Local Institution - 0070
Grenoble, 38043, France
Local Institution - 0074
Le Havre, 76083, France
Local Institution - 0167
Le Kremlin-Bictre, 94270, France
Local Institution - 0025
Paris, 75012, France
Local Institution - 0107
Paris, 75014, France
Local Institution - 0057
Paris, 75651, France
Local Institution - 0079
Munich, Bavaria, 80336, Germany
Local Institution - 0092
Berlin, 10117, Germany
Local Institution - 0031
Freiburg im Breisgau, 79106, Germany
Local Institution - 0033
Hamburg, 20095, Germany
Local Institution - 0075
Tübingen, 72076, Germany
Local Institution - 0051
Würzburg, 97080, Germany
Local Institution - 0077
Athens, 11527, Greece
Local Institution - 0108
Larissa, 41110, Greece
Local Institution - 0083
Debrecen, 4032, Hungary
Local Institution - 0090
Gyula, 5700, Hungary
Local Institution - 0145
Ramat Gan, IA, 5265601, Israel
Local Institution - 0142
Kfar Saba, 4428164, Israel
Local Institution - 0065
Brescia, 25123, Italy
Local Institution - 0029
Milan, 20122, Italy
Local Institution - 0124
Naples, 80131, Italy
Local Institution - 0128
Pisa, 56126, Italy
Local Institution - 0069
Rome, 00128, Italy
Local Institution - 0081
Udine, 33100, Italy
Local Institution - 0146
Nagoya, Aichi-ken, 457-8511, Japan
Local Institution - 0205
Toyoake-shi, Aichi-ken, 470-1192, Japan
Local Institution - 0148
Kitakyushu-shi, Fukuoka, 807-8556, Japan
Local Institution - 0122
Sapporo, Hokkaido, 0608543, Japan
Local Institution - 0188
Sapporo, Hokkaido, 0608648, Japan
Local Institution - 0211
Nishinomiya-shi, Hyōgo, 6638501, Japan
Local Institution - 0193
Tsukuba, Ibaraki, 3058576, Japan
Local Institution - 0202
Kahoku-gun, Ishikawa-ken, 9200293, Japan
Local Institution - 0118
Kanazawa, Ishikawa-ken, 9208641, Japan
Local Institution - 0206
Kawasaki-shi, Kanagawa, 2168511, Japan
Local Institution - 0191
Yokohama, Kanagawa, 2458575, Japan
Local Institution - 0139
Sendai, Miyagi, 980-8574, Japan
Local Institution - 0147
Nagasaki, Nagasaki, 8528501, Japan
Local Institution - 0129
Sasebo, Nagasaki, 8571195, Japan
Local Institution - 0207
Kurashiki, Okayama-ken, 7100824, Japan
Local Institution - 0198
Ōtsu, Shiga, 5250072, Japan
Local Institution - 0194
Hamamatsu, Shizuoka, 4313192, Japan
Local Institution - 0195
Shimotsugagun, Tochigi, 3210293, Japan
Local Institution - 0210
Bunkyo-ku, Tokyo, 1138421, Japan
Local Institution - 0196
Bunkyo-ku, Tokyo, 1138519, Japan
Local Institution - 0190
Chuo-ku, Tokyo, 1048560, Japan
Local Institution - 0201
Meguro-ku, Tokyo, 1528902, Japan
Local Institution - 0208
Meguro-ku, Tokyo, 1538515, Japan
Local Institution - 0204
Shinagawa-ku, Tokyo, 1420054, Japan
Local Institution - 0197
Shinjuku, Tokyo, 1608582, Japan
Local Institution - 0192
tabashi City, Tokyo, 1738610, Japan
Local Institution - 0020
León, Guanajuato, 37000, Mexico
Local Institution - 0023
Guadalajara, Jalisco, 44620, Mexico
Local Institution - 0048
Guadalajara, Jalisco, 44690, Mexico
Local Institution - 0169
Mexico City, Mexico City, 11850, Mexico
Local Institution - 0001
Groningen, 9713 GZ, Netherlands
Local Institution - 0105
Rotterdam, 3015 GD, Netherlands
Local Institution - 0047
Jesus Maria, Lima region, 15076, Peru
Local Institution - 0011
Santiago de Surco, Lima region, 1111, Peru
Local Institution - 0171
Lima, Lima 26, Peru
Local Institution - 0084
Krakow, Lesser Poland Voivodeship, 30-363, Poland
Local Institution - 0054
Warsaw, Masovian Voivodeship, 00-874, Poland
Local Institution - 0141
Warsaw, Woj. Mazowieckie, 02-118, Poland
Local Institution - 0024
Bydgoszcz, 85-065, Poland
Local Institution - 0085
Bydgoszcz, 85-168, Poland
Local Institution - 0040
Lublin, 20-412, Poland
Local Institution - 0089
Poznan, 60-693, Poland
Local Institution - 0080
Warsaw, 02 665, Poland
Local Institution - 0076
Warsaw, 02-637, Poland
Local Institution - 0185
Warsaw, 03-291, Poland
Local Institution - 0064
Wroclaw, 53-224, Poland
Local Institution - 0036
Wroclaw, 54-049, Poland
Local Institution - 0028
Lisbon, 1050-078, Portugal
Local Institution - 0014
Lisbon, 1649-035, Portugal
Local Institution - 0143
San Juan, 00917, Puerto Rico
Local Institution - 0127
San Juan, 00918, Puerto Rico
Local Institution - 0220
Cluj-Napoca, Cluj, 400006, Romania
Local Institution - 0041
Brasov, 500283, Romania
Local Institution - 0219
Bucharest, 011658, Romania
Local Institution - 0110
Seongdong-gu, Seoul, 04763, South Korea
Local Institution - 0042
Gwangju, 61469, South Korea
Local Institution - 0126
Seoul, 06591, South Korea
Local Institution - 0209
Seoul, 5030, South Korea
Local Institution - 0038
Mérida, Badajoz, 06800, Spain
Local Institution - 0059
Santander, Cantabria, 39008, Spain
Local Institution - 0114
San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain
Local Institution - 0112
A Coruña, 15006, Spain
Local Institution - 0068
Santiago de Compostela, 15702, Spain
Local Institution - 0071
Seville, 41010, Spain
Local Institution - 0166
Gothenburg, 405 30, Sweden
Local Institution - 0164
Stockholm, 11361, Sweden
Local Institution - 0013
Bern, 3010, Switzerland
Local Institution - 0034
Sankt Gallen, 9007, Switzerland
Local Institution - 0116
Kaohsiung City, 83301, Taiwan
Local Institution - 0012
Taichung, 40447, Taiwan
Local Institution - 0002
Taichung, 40705, Taiwan
Local Institution - 0027
Taipei, 100, Taiwan
Local Institution - 0045
Taoyuan, 333, Taiwan
Local Institution - 0035
Yenimahalle, Ankara, 06500, Turkey (Türkiye)
Local Institution - 0088
Ankara, 06100, Turkey (Türkiye)
Local Institution - 0007
Antalya, 7058, Turkey (Türkiye)
Local Institution - 0044
Istanbul, 34098, Turkey (Türkiye)
Local Institution - 0176
Southampton, Hampshire, SO16 6YD, United Kingdom
Local Institution - 0217
Wolverhampton, West Midlands, WV10 0QP, United Kingdom
Local Institution - 0030
Birmingham, B15 2WB, United Kingdom
Local Institution - 0060
Cannock, WS11 5XY, United Kingdom
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bristol-Myers Squibb
Bristol-Myers Squibb
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2023
First Posted
July 14, 2023
Study Start
September 11, 2023
Primary Completion (Estimated)
November 18, 2026
Study Completion (Estimated)
November 16, 2028
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- See Plan Description
- Access Criteria
- See Plan Description
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html